Moderna's GAAP loss for 6 months of 2023 was $1.301 billion, against a profit of $5.854 billion in the prior year. Revenue declined 5-fold to $2.206 billion versus $10.815 billion a year earlier.
Moderna's GAAP loss for 6 months of 2023 was $1.301 billion, against a profit of $5.854 billion in the prior year. Revenue declined 5-fold to $2.206 billion versus $10.815 billion a year earlier. 
English (US) 